We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Statistics enable/disable

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name	econda
Purpose	Statistics

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Joint Subproject 1

Immune protection and immune pathology in experimental models of SARS-CoV-2 infection

The overall goal of this sub-project is to define the role of immune cells, cytokines and latent virus reactivation in the control and pathogenesis of SARS-CoV-2 infection and to determine in vivo the prophylactic and therapeutic effect of a class of host-targeting drugs to suppress SARS-CoV-2 and other respiratory viruses with pandemic potential.
To reach this goal, we pursue three aims that will help to clarify highly relevant questions related to viral and immune pathology of COVID-19.
In line with the Transfer mission of COVIPA, we aim to bring forward a novel broad-spectrum therapeutic concept that is based on blocking host cell chaperones of relevance to the replication of coronaviruses and possibly several other viruses of pandemic potential and to cellular inflammatory response.

Luka Čičin-Šain
Luka.Cicin-Sain@helmholtz-hzi.de

Markus Landthaler
markus.landthaler@mdc-berlin.de